Hiroo Yokozeki Selected Research

Hiroo Yokozeki Research Topics

Disease

19	Inflammation (Inflammations) 12/2021 - 08/2005
9	Melanoma (Melanoma, Malignant) 08/2023 - 02/2005
9	Contact Dermatitis (Eczema, Contact) 12/2021 - 09/2003
8	Hypersensitivity (Allergy) 07/2023 - 11/2010
8	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2002
8	Skin Diseases (Skin Disease) 12/2021 - 09/2003
5	Prurigo 04/2024 - 05/2015
5	Hyperhidrosis 11/2023 - 03/2021
5	Neoplasms (Cancer) 02/2020 - 04/2011
4	Urticaria (Hives) 12/2021 - 09/2003
4	Pruritus (Itching) 09/2021 - 03/2012
4	Myositis (Idiopathic Inflammatory Myopathies) 09/2019 - 08/2009
4	Eosinophilia 09/2016 - 09/2003
3	Anaphylaxis (Anaphylactic Shock) 12/2022 - 01/2017
3	Bowen's Disease (Disease, Bowen) 02/2020 - 01/2004
3	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2012 - 07/2005
2	Carcinogenesis 08/2023 - 02/2007
2	Exercise-Induced Allergies 07/2023 - 01/2021
2	Food Hypersensitivity (Food Allergy) 01/2021 - 01/2017
2	Tuberous Sclerosis (Bourneville's Disease) 08/2020 - 01/2018
2	Hemangiosarcoma (Angiosarcoma) 02/2020 - 10/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2020 - 09/2016
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2018 - 07/2009
2	Arthralgia (Joint Pain) 05/2017 - 02/2005
2	Vasculitis (Vasculitides) 01/2017 - 01/2017
2	Erythema 09/2016 - 04/2007
2	Neoplasm Metastasis (Metastasis) 08/2016 - 01/2013
2	Localized Scleroderma (Morphea) 01/2016 - 09/2003
2	Polymyositis 07/2015 - 08/2009
2	Drug Eruptions (Drug Eruption) 01/2014 - 05/2011
2	Eosinophilic pustular folliculitis 09/2013 - 01/2010
2	Edema (Dropsy) 04/2009 - 04/2003
2	Seasonal Allergic Rhinitis (Hay Fever) 04/2007 - 01/2006
1	red meat allergy 12/2022
1	Mydriasis 01/2022
1	Dysuria 01/2022
1	Photophobia (Light Sensitivity) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 08/2021
1	Cysts 05/2021
1	Hypohidrosis 03/2021
1	Actinic Keratosis 02/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 02/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2020

Drug/Important Bio-Agent (IBA)

11	Immunoglobulin E (IgE)IBA 12/2021 - 08/2005
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2007
7	AntigensIBA 12/2021 - 08/2005
7	Prostaglandin D2IBA 09/2013 - 08/2006
5	CytokinesIBA 01/2023 - 09/2003
5	Therapeutic UsesIBA 10/2013 - 08/2009
4	NivolumabIBA 01/2019 - 08/2016
4	LigandsIBA 11/2012 - 01/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 06/2002
3	Omalizumab (Xolair)FDA Link 07/2023 - 10/2018
3	SteroidsIBA 05/2021 - 09/2016
3	Methotrexate (Mexate)FDA LinkGeneric 05/2018 - 02/2005
3	P-SelectinIBA 09/2013 - 01/2002
3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 09/2013 - 01/2008
2	oxybutynin (Tavor)FDA LinkGeneric 11/2023 - 01/2023
2	PeriostinIBA 01/2023 - 01/2019
2	Thymic Stromal LymphopoietinIBA 01/2023 - 01/2019
2	Cetuximab (Erbitux)FDA Link 12/2022 - 01/2018
2	Histamine Antagonists (Antihistamines)IBA 09/2021 - 09/2003
2	BromidesIBA 08/2021 - 03/2021
2	Sirolimus (Rapamycin)FDA Link 08/2020 - 01/2018
2	trans-sodium crocetinate (crocetin)IBA 08/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 10/2019 - 08/2014
2	OligodeoxyribonucleotidesIBA 07/2019 - 01/2012
2	Infliximab (Remicade)FDA Link 12/2018 - 05/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 09/2016
2	Immunoglobulin A (IgA)IBA 01/2017 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015 - 11/2012
2	Phosphotransferases (Kinase)IBA 07/2015 - 04/2011
2	AntibodiesIBA 07/2015 - 11/2013
2	HaptensIBA 08/2014 - 08/2006
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 09/2010
2	Amyloid (Amyloid Fibrils)IBA 02/2014 - 09/2003
2	E-SelectinIBA 09/2013 - 01/2002
2	Indomethacin (Indometacin)FDA LinkGeneric 09/2013 - 01/2010
2	Interleukin-17 (Interleukin 17)IBA 07/2012 - 08/2009
2	prostaglandin D2 receptorIBA 10/2011 - 08/2006
2	SelectinsIBA 09/2005 - 01/2002
1	nemolizumabIBA 04/2024
1	Serine (L-Serine)FDA Link 08/2023
1	AllergensIBA 07/2023
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2022
1	glycopyrronium tosylateIBA 01/2022
1	PapainIBA 12/2021
1	ParvalbuminsIBA 10/2021
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 09/2021
1	Syntex adjuvant formulationIBA 08/2021
1	SiliconIBA 05/2021
1	Hair DyesIBA 02/2021
1	4-phenylenediamine (p-phenylenediamine)FDA Link 02/2021
1	P-2 (P 2)IBA 01/2021
1	Monoclonal AntibodiesIBA 02/2020
1	AutoantibodiesIBA 09/2019

Therapy/Procedure

13	Therapeutics 03/2021 - 01/2012
2	Immunotherapy 10/2021 - 01/2021
2	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 01/2013